Overview of drug therapy for multiple myeloma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2005, v. 11, n. 3, p. 83, doi. 10.1191/1078155205jp160oa
- By:
- Publication type:
- Article
Works matching IS 10781552 AND DT 2005 AND VI 11 AND IP 3
Results: 5
1
2
Antineoplastic agent workplace contamination study: the Alberta Cancer Board Pharmacy perspective.
- Published in:
- Journal of Oncology Pharmacy Practice, 2005, v. 11, n. 3, p. 101, doi. 10.1191/1078155205jp152oa
- By:
- Publication type:
- Article
3
Strategies for management of the peritoneal surface component of cancer: cytoreductive surgery plus perioperative intraperitoneal chemotherapy.
- Published in:
- Journal of Oncology Pharmacy Practice, 2005, v. 11, n. 3, p. 111, doi. 10.1191/1078155205jp157oa
- By:
- Publication type:
- Article
4
Palifermin (Kepivance<sup>™</sup>) for the treatment of oral mucositis in patients with hematologic malignancies requiring hematopoietic stem cell support.
- Published in:
- Journal of Oncology Pharmacy Practice, 2005, v. 11, n. 3, p. 121, doi. 10.1191/1078155205jp159oa
- By:
- Publication type:
- Article
5
Interstitial lung disease following erlotinib (Tarceva<sup>®</sup>) in a patient who previously tolerated gefitinib (Iressa<sup>®</sup>).
- Published in:
- Journal of Oncology Pharmacy Practice, 2005, v. 11, n. 3, p. 127, doi. 10.1191/1078155205jp158cr
- By:
- Publication type:
- Article